Dr. Michael S Gordon, MD
Claim this profileHonor Health Research Institute
About Michael S Gordon, MD
Education:
- Holds an MD (Doctor of Medicine).
- Earned a PhD in an unspecified field.
Experience:
- Pioneered the creation of Harvey, the first cardiopulmonary patient simulator, at the University of Miami's Leonard M. Miller School of Medicine.
- Developed UMedic, a cutting-edge program for medical education.
- Founded the Michael S. Gordon Center for Research in Medical Education.
- Specializes in Hematology, Medical Oncology, and Internal Medicine at HonorHealth Research Institute.
- Recognized with the AXA Advisors Lifetime Achievement Award for contributions to healthcare.
- Provided significant support and funding for medical education and innovation.
Area of expertise
Solid Tumors
Michael S Gordon, MD has run 8 trials for Solid Tumors. Some of their research focus areas include:
Cancer
Michael S Gordon, MD has run 7 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
HonorHealth Research Institute
HonorHealth
Clinical Trials Michael S Gordon, MD is currently running
Dabrafenib + Trametinib Access
for Cancer
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-sponsored study who have fulfilled the requirements for the primary objective, and who are judged by the investigator as benefiting from continued treatment in the parent study as judged by the Investigator at the completion of the parent study.
Recruiting
3 awards
Phase 4
2 criteria
DCSZ11 + Pembrolizumab
for Advanced Cancer
This trial is testing DCSZ11, a drug that helps the immune system attack cancer cells by targeting a specific protein. It is aimed at patients with advanced or metastatic solid tumors. The study will determine the best dose and assess its effectiveness both alone and in combination with another drug, pembrolizumab, which has shown efficacy in various cancers.
Recruiting
1 award
Phase 1
More about Michael S Gordon, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Michael S Gordon, MD has experience with
- Nivolumab
- Botensilimab
- Pembrolizumab
- Docetaxel
- Dostarlimab
- OR2805
Breakdown of trials Michael S Gordon, MD has run
Solid Tumors
Cancer
Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael S Gordon, MD specialize in?
Michael S Gordon, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are EGFR positive.
Is Michael S Gordon, MD currently recruiting for clinical trials?
Yes, Michael S Gordon, MD is currently recruiting for 4 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Michael S Gordon, MD has studied deeply?
Yes, Michael S Gordon, MD has studied treatments such as Nivolumab, Botensilimab, Pembrolizumab.
What is the best way to schedule an appointment with Michael S Gordon, MD?
Apply for one of the trials that Michael S Gordon, MD is conducting.
What is the office address of Michael S Gordon, MD?
The office of Michael S Gordon, MD is located at: Honor Health Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the Honor Health Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.